Kingsview Wealth Management’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
Kingsview Wealth Management's DGX Position: Q2 2025 in Review
Kingsview Wealth Management sold out of Quest Diagnostics (DGX) in Q2 2025, closing a stake of 17,184 shares — an estimated $2.91M sold.
Kingsview Wealth Management first reported a position in DGX in Q3 2019 and held it in 16 quarters. The position peaked at $2.91M in Q1 2025. 991 funds tracked by Wall St. Rank hold DGX as of Q2 2025.
- Kingsview Wealth Management reported no remaining Quest Diagnostics position as of Q2 2025 after selling out during the quarter.
- Kingsview Wealth Management sold 17,184 Quest Diagnostics shares in Q2 2025, an estimated $2.91M.
- Kingsview Wealth Management first reported a position in Quest Diagnostics in Q3 2019 and held it in 16 quarters.
- Kingsview Wealth Management's Quest Diagnostics position peaked at $2.91M in Q1 2025.
- 991 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2025.
Based on Kingsview Wealth Management's 13F filing for Q2 2025, filed 8 Aug 2025.